The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer

• Jingjing Liu ,

  Contributed equally to this work with: Jingjing Liu, Anieta M. Sieuwerts

  Affiliation Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands

  ⨯
• Anieta M. Sieuwerts ,

  Contributed equally to this work with: Jingjing Liu, Anieta M. Sieuwerts

  Affiliations Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands, Cancer Genomics Netherlands, Utrecht, the Netherlands

  ⨯
• Maxime P. Look,

  Affiliation Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands

  ⨯
• Michelle van der Vlugt-Daane,

  Affiliation Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands

  ⨯
• Marion E. Meijer-van Gelder,

  Affiliation Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands

  ⨯
• John A. Foekens,

  Affiliation Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands

  ⨯
• Antoinette Hollestelle ,

  * E-mail: a.hollestelle@erasmusmc.nl

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands

  http://orcid.org/0000-0003-1166-1966

  ⨯
• John W. M. Martens

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands

  ⨯